Nkarta Therapeutics racks up $114 mln Series B
South San Francisco-based Nkarta Therapeutics, a biopharmaceutical company focused on fighting cancer, has raised $114 million in Series B financing. Samsara BioCapital led the round.
5 September 2019•1 min read
